Metabolic Determinants of PCSK9 Regulation in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance, Obesity, and Tobacco Smoke Exposure. [PDF]
Int J Mol SciNiepsuj J +3 more
europepmc +1 more source
Familial Hypercholesterolaemia and the Risk of Cardiovascular Events. [PDF]
CureusConchinha A +4 more
europepmc +1 more source
LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice [PDF]
, 2018 Jeong, Lak Shin +5 more
core +1 more source
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: comparing and contrasting guidance across the Atlantic [PDF]
, 2016 Marc S. Sabatine
openalex +1 more source
Blocking PCSK9 suppresses hepatocellular carcinoma immune escape by decreasing FLI1-mediated SPP1 and PD-L1 expression. [PDF]
J Immunother CancerHu C +12 more
europepmc +1 more source
Can proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors regress coronary atherosclerotic plaque? A systematic review and meta-analysis. [PDF]
, 2023 Zijia Wu, Lulan Gao, Zhihai Lin
openalex
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: A Novel Therapy in the Treatment of Cholesterol Crystal Embolism-Induced Kidney Injury. [PDF]
Kidney MedStrimaitis BJ, Francis L, O'Sullivan ED.
europepmc +1 more source
Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia. [PDF]
HeartRoger G +5 more
europepmc +1 more source
Progression of Established Atherosclerotic Lesions Is Not Inhibited by Endothelial Knockout of Caveolin-1-Brief Report. [PDF]
Arterioscler Thromb Vasc BiolMuñiz-Anquela R +8 more
europepmc +1 more source